DK0506868T3 - Immunologisk aktive proteiner fra Borrelia burgdorferi, tilhørende testkits og vaccine - Google Patents

Immunologisk aktive proteiner fra Borrelia burgdorferi, tilhørende testkits og vaccine

Info

Publication number
DK0506868T3
DK0506868T3 DK91902687.2T DK91902687T DK0506868T3 DK 0506868 T3 DK0506868 T3 DK 0506868T3 DK 91902687 T DK91902687 T DK 91902687T DK 0506868 T3 DK0506868 T3 DK 0506868T3
Authority
DK
Denmark
Prior art keywords
immunologically active
proteins
borrelia burgdorferi
active proteins
specific
Prior art date
Application number
DK91902687.2T
Other languages
English (en)
Other versions
DK0506868T4 (da
Inventor
Renate Fuchs
Bettina Wilske
Vera Preac-Mursic
Manfred Motz
Erwin Soutschek
Original Assignee
Mikrogen Molekularbiol Entw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25888425&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0506868(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE3942728A external-priority patent/DE3942728C1/de
Priority claimed from DE4018988A external-priority patent/DE4018988C2/de
Application filed by Mikrogen Molekularbiol Entw filed Critical Mikrogen Molekularbiol Entw
Publication of DK0506868T3 publication Critical patent/DK0506868T3/da
Application granted granted Critical
Publication of DK0506868T4 publication Critical patent/DK0506868T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1207—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK91902687T 1989-12-22 1990-12-21 Immunologisk aktive proteiner fra Borrelia burgdorferi, tilhørende testkits og vaccine DK0506868T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3942728A DE3942728C1 (en) 1989-12-22 1989-12-22 New immunologically active proteins derived from Borelia burgdorferiensity polyethylene vessel and a high density polyethylene sealing cap - useful as vaccine and for quick accurate diagnosis of Borelia infections
DE4018988A DE4018988C2 (de) 1990-06-13 1990-06-13 Immunologisch aktive Proteine von Borrelia burgdorferi, Testkits, die diese Proteine enthalten und zum Nachweis von Antikörpern in Untersuchungsflüssigkeiten geeignet sind, monoklonale Antikörper, die gegen die immunologisch aktiven Proteine gerichtet sind und die Verwendung dieser Proteine als Impfstoffe gegen durch Borrelia-Stämme hervorgerufene Infektionen
PCT/EP1990/002282 WO1991009870A1 (de) 1989-12-22 1990-12-21 Immunologisch aktive proteine von borrelia burgdorferi, zusammenhängende testkits und impfstoff

Publications (2)

Publication Number Publication Date
DK0506868T3 true DK0506868T3 (da) 1996-08-12
DK0506868T4 DK0506868T4 (da) 2004-04-26

Family

ID=25888425

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91902687T DK0506868T4 (da) 1989-12-22 1990-12-21 Immunologisk aktive proteiner fra Borrelia burgdorferi, tilhørende testkits og vaccine

Country Status (9)

Country Link
US (5) US6248538B1 (da)
EP (1) EP0506868B2 (da)
AT (1) ATE140461T1 (da)
AU (1) AU7058691A (da)
CA (1) CA2072008C (da)
DE (1) DE59010422D1 (da)
DK (1) DK0506868T4 (da)
ES (1) ES2092560T5 (da)
WO (1) WO1991009870A1 (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143872A (en) * 1988-10-24 2000-11-07 Symbicom Aktiebolag Borrelia burdorferi Osp A and B proteins and immunogenic peptides
US5777095A (en) * 1988-10-24 1998-07-07 Symbicom Aktiebolag Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
DE4015911A1 (de) * 1989-09-19 1991-03-28 Max Planck Gesellschaft Impfstoff gegen die lyme-krankheit
ES2092560T5 (es) * 1989-12-22 2004-09-16 Mikrogen Molekularbiologische Entwicklungs-Gmbh Proteinas inmunologicamente activas de borrelia burgdorferi, estuches de ensayo relacionados y vacuna.
SG47447A1 (en) * 1990-06-15 1998-04-17 Univ Yale Compositions and methods for the prevention and diagnosis of lyme disease
HU216204B (hu) * 1990-06-15 1999-05-28 MTA Műszaki Fizikai és Anyagtudományi Kutatóintézet Eljárás és berendezés kis mágneses terek és térváltozások mérésére, valamint magnetométer szonda
DE4120345C5 (de) * 1991-06-19 2004-08-12 Arnold Prof. Dr.med. Vogt Proteinfragmente aus dem mittleren Bereich des Flagellins von Borrelia burgdorferi, geeignet als Antigene zum spezifischen Antikörpernachweis sowie Verfahren zu ihrer Herstellung
US6221363B1 (en) * 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
US6872550B1 (en) 1991-07-11 2005-03-29 Baxter Vaccine Ag Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
US6676942B1 (en) * 1991-08-15 2004-01-13 Smithkline Beecham Biologicals (S.A.) Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
AU676140B2 (en) * 1991-10-18 1997-03-06 Connaught Laboratories Inc. Preparation of recombinant borrelia proteins
JPH07501797A (ja) * 1991-11-12 1995-02-23 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ ライム病に対する組換えワクチン
US5618533A (en) * 1992-02-11 1997-04-08 Yale University Flagellin-based polypeptides for the diagnosis of lyme disease
AU4392093A (en) * 1992-05-26 1993-12-30 Government of the United States of America, as Represented by the Secretary, Department of Health and Human Services, Centers for Disease Control and Prevention, The Compositions useful in diagnosis and prophylaxis of lyme disease
US6031087A (en) 1992-12-16 2000-02-29 The University Of Melbourne Proteinase inhibitor, precursor thereof and genetic sequences encoding same
US6716591B1 (en) 1993-07-30 2004-04-06 Yale University B. burgdorferi polypeptides
US5656451A (en) * 1993-07-30 1997-08-12 Yale University OspE, OspF, and S1 polypeptides in borrelia burgdorferi
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
US6248562B1 (en) 1993-11-01 2001-06-19 Research Foundation State University Of New York Chimeric proteins comprising borrelia polypeptides and uses therefor
US5620862A (en) * 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease
US6251405B1 (en) 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
ZA964896B (en) 1995-06-07 1997-01-08 Connaught Lab Expression of lipoproteins
US6716574B2 (en) 1996-05-02 2004-04-06 Dako A/S Osp-C derived peptide fragments
ATE337335T1 (de) 1997-06-30 2006-09-15 Univ Tulane Oberflächenantigene und proteine für zusammensetzungen zu diagnose und vorbeugung der lyme-kkrankheit
US6224882B1 (en) 1997-11-07 2001-05-01 Protein Science Corp. Insect cells or fractions as adjuvant for antigens
US6475492B1 (en) 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
DK1311540T3 (da) 2000-08-18 2008-04-28 Brookhaven Sciences Ass Llc Ændret OspA af Borrelia Burgdorferi
AU2002247905A1 (en) * 2002-03-28 2003-10-13 Markus Fritzsche Antibody against an epitope of the b. burgdorferi flagellar basal rod protein (fbrp)
US20040033623A1 (en) * 2002-08-16 2004-02-19 Igenex, Inc. Assay for detection of antigen in bodily fluid
EP2059526A2 (en) 2006-09-15 2009-05-20 Intercell AG Borrelia antigens
EP2155782A2 (en) 2007-03-26 2010-02-24 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP2167536A1 (en) 2007-07-03 2010-03-31 Dako Denmark A/S Mhc multimers, methods for their generation, labeling and use
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
DK2254592T3 (da) 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
WO2009133378A2 (en) 2008-05-02 2009-11-05 Cancer Research Technology Ltd. Products and methods for stimulating an immune response
WO2010009735A2 (en) 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
EP2199303B1 (de) 2008-12-12 2013-06-05 Euroimmun Medizinische Labordiagnostika AG Polypeptide und Verfahren zur spezifischen Detektion von Antikörpern bei Patienten mit einer Borrelieninfektion
EA025280B1 (ru) 2010-03-09 2016-12-30 Амир Максютов Полиэпитопные конструкции и способы их получения и применения
US8142050B2 (en) 2010-06-24 2012-03-27 Mitutoyo Corporation Phosphor wheel configuration for high intensity point source
US9109007B2 (en) 2010-08-18 2015-08-18 Purdue Pharma L.P. MHC-I restricted epitopes containing non-natural amino acid residues
WO2013067448A2 (en) 2011-11-03 2013-05-10 Vca Antech Inc. Compositions and methods to detect various infectious organisms
WO2023240124A1 (en) 2022-06-07 2023-12-14 Regeneron Pharmaceuticals, Inc. Pseudotyped viral particles for targeting tcr-expressing cells
WO2023240109A1 (en) 2022-06-07 2023-12-14 Regeneron Pharmaceuticals, Inc. Multispecific molecules for modulating t-cell activity, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888276A (en) * 1986-06-26 1989-12-19 Minnesota Mining And Manufacturing Company Method and composition for the diagnosis of Lyme disease
ES2092560T5 (es) * 1989-12-22 2004-09-16 Mikrogen Molekularbiologische Entwicklungs-Gmbh Proteinas inmunologicamente activas de borrelia burgdorferi, estuches de ensayo relacionados y vacuna.
US5620862A (en) 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease

Also Published As

Publication number Publication date
AU7058691A (en) 1991-07-24
US6753183B2 (en) 2004-06-22
EP0506868A1 (de) 1992-10-07
US20030157562A1 (en) 2003-08-21
WO1991009870A1 (de) 1991-07-11
US6509019B1 (en) 2003-01-21
CA2072008C (en) 2003-01-28
ES2092560T5 (es) 2004-09-16
EP0506868B1 (de) 1996-07-17
ATE140461T1 (de) 1996-08-15
US6183755B1 (en) 2001-02-06
EP0506868B2 (de) 2004-02-11
ES2092560T3 (es) 1996-12-01
DK0506868T4 (da) 2004-04-26
US6248538B1 (en) 2001-06-19
US7083792B2 (en) 2006-08-01
DE59010422D1 (de) 1996-08-22
US20040253611A1 (en) 2004-12-16
CA2072008A1 (en) 1991-06-23

Similar Documents

Publication Publication Date Title
DK0506868T4 (da) Immunologisk aktive proteiner fra Borrelia burgdorferi, tilhørende testkits og vaccine
Strand et al. Type-C RNA virus gene expression in human tissue
Iqbal et al. Comparison of PCR with other tests for early diagnosis of canine ehrlichiosis
Núñez et al. Multiplex polymerase chain reaction amplification and differentiation of Entamoeba histolytica and Entamoeba dispar DNA from stool samples.
ES8507177A1 (es) Un metodo para detectar bacterias en una muestra a ensayar
KR0171617B1 (ko) 단백질-핵산 프로브 및 그를 사용하는 면역분석법
DE60128908D1 (de) Verfahren zum Nachweis und zur Lokalisierung von Genen in situ durch Hybridisierung einer verzweigten DNA
ATE459716T1 (de) Zytokin zcyt018
ES2003339A6 (es) Procedimiento para la preparacion de grupos diferenciados de anticuerpos.
Rola et al. The detection of bovine leukemia virus proviral DNA by PCR–ELISA
US6322989B1 (en) Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
Wagter et al. PCR detection of lentiviral GAG segment DNA in the white blood cells of sheep and goats
CN104726606A (zh) 一种pcr酶联双杂交法检测病原微生物检测方法
WO1991011534A1 (en) A rapid and sensitive test for detecting hepatitis a virus
CN108330214A (zh) 快速检测牛白血病前病毒的rpa引物及试剂和试剂盒
JPH0556800A (ja) 単純ヘルペスウイルスの型特異的検出方法
US6268123B1 (en) Direct and biochemically functional detection process of retrovirus in biological samples
Gupte et al. Diagnostic approach to brucellosis
JPH11511027A (ja) Ｇｂ型肝炎ウィルス遺伝子型の検出
Sauer et al. Identification of Ophiosphaerella herpotricha by cloned DNA probes.
RU2164945C1 (ru) Синтетические олигонуклеотиды-праймеры, используемые для выявления днк цитомегаловируса человека
RU2133622C1 (ru) Способ обнаружения антител к ядерному белку вируса гепатита с
KR970011310B1 (ko) 핵산증폭용 프라이머를 이용한 바이러스 진단방법
RU2206574C2 (ru) Полипептид, содержащий антигенный участок растворимого антигена м. tuberculosis, способ (варианты) и диагностический набор (варианты) для выявления инфекции m. tuberculosis
EP0543222A1 (en) Method for detecting nucleic acids and relative diagnostic kit